Unlocking Therapeutics with LIGHT

Our Platform's Mechanism

1

2

3

Encapsulate

Drug of choice is concealed within our light-responsive lipid carrier

Administer

Encapsulated drug circulates systemically in an inactive state, unable to cause off-target side effects

Activate

Wavelength-specific light triggers localized release from the carrier, activating the drug only at the illuminated site for a targeted therapeutic response

Journal of Controlled Release

Medical Oncologist

“There is still so much off target toxicity with most of the antibody drug conjugates … being able to target things like that would be great.”

Indications

An externally controllable, plug-and-play platform enabling safer treatment of many indications with various APIs

Lipid carriers are compatible with drugs across modalities & sizes, from small molecules to biologics
Light-activated delivery that is adaptable to a broad range of indications
Preclinical studies spanning multiple disease areas are ongoing